← Back to Clinical Trials
Recruiting NCT06630975

NCT06630975 Hemiepiphysiodesis by Eight Plate Versus Osteotomy in the Management of Pediatric Coronal Knee Deformities

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06630975
Status Recruiting
Phase
Sponsor Al-Azhar University
Condition Genu Varum
Study Type INTERVENTIONAL
Enrollment 2 participants
Start Date 2024-09-25
Primary Completion 2025-10-01

Eligibility & Interventions

Sex All sexes
Min Age 2 Years
Max Age 18 Years
Study Type INTERVENTIONAL
Interventions
HemiepiphysiodesisEight-Plates first described by Stevens are simple to useHemiepiphysiodesis by eight Plate

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 2 participants in total. It began in 2024-09-25 with a primary completion date of 2025-10-01.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

Coronal angular deformities of lower limb in children are a common finding in pediatric orthopedic surgery.These angular deformities can be idiopathic in origin, or they can emerge secondary to congenital and acquired abnormalities. Persistent coronal plane deformities around knee (genu varum/valgum) could lead to meniscal tears, collateral ligament laxity, cartilage degeneration, and early osteoarthritis due to gradual mechanical axis disruption

Eligibility Criteria

Inclusion Criteria: * Growth plate still open at Time of Surgery Exclusion Criteria: * Epiphyseal plate involved in trauma resulting in a bridging callus formation,

Frequently Asked Questions

Who can join the NCT06630975 clinical trial?

This trial is open to participants of all sexes, aged 2 Years or older, up to 18 Years, studying Genu Varum. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT06630975 currently recruiting?

Yes, NCT06630975 is actively recruiting participants. Visit ClinicalTrials.gov or contact Al-Azhar University to inquire about joining.

Where is the NCT06630975 trial being conducted?

This trial is being conducted at Asyut, Egypt.

Who is sponsoring the NCT06630975 clinical trial?

NCT06630975 is sponsored by Al-Azhar University. The trial plans to enroll 2 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: July 2026  ·  Data Methodology